£9.0M
Plural led the Series A follow-on round to help the company scale its precision medicine platform and expand globally.
Sano Genetics
Sano Genetics provides a comprehensive software platform for precision medicine clinical trials.
£20.3MTotal raised
Sano Genetics builds software designed to streamline precision medicine clinical trials by combining patient recruitment, genetic testing and ongoing engagement into a single platform. The company works with major pharmaceutical firms and research institutions to accelerate medical breakthroughs.
Filed accounts
Cash at bank
Members only
Net current assets
Members only
Total assets less current liabilities
Members only
Net assets
Members only
Shareholders' funds
Members only
Fixed assets
Members only
Cash, assets and headcount from Sano Genetics's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Founders
Patrick Short
CEO
Patrick brings genomic and machine learning experience, currently serving as co-founder and CEO of Sano Genetics after completing a PhD in mathematical genomics and medicine.
LinkedInCG
Charlotte Guzzo
COO
William Jones
CTO
William co-founded Sano Genetics, where he served as chief technology officer for seven years. He previously held roles at Faculty and The Genome Analysis Centre.
LinkedInInvestors
- £9.0M
- £8.3M
- £2.5M
- £500K
Funding history
£8.3M
The Series A round was led by MMC Ventures with participation from Episode 1, Seedcamp, and angel investors.
£2.5M
The seed round was led by Episode1 with backing from Seedcamp, Cambridge Enterprise, and January Ventures to fund DNA testing kits and platform development.
£500K
The seed round was supported by Seedcamp alongside Cambridge Enterprise, angel investors, and grant providers.